Skip to main content
Tempest Therapeutics, Inc. logo

Tempest Therapeutics, Inc. — Investor Relations & Filings

Ticker · TPST ISIN · US69014Q1013 US Professional, scientific and technical activities
Open in API
Filings indexed 987 across all filing types
Latest filing 2012-10-30 Board/Management Inform…
Country US United States of America
Listing US TPST

About Tempest Therapeutics, Inc.

https://www.tempesttx.com/

Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates and cell therapies. The company develops first-in-class therapeutics that combine tumor-targeted and immune-mediated mechanisms to treat cancer. Its lead product candidate is amezalpat (TPST-1120), an oral, selective PPARα antagonist being evaluated in a global, randomized combination study for hepatocellular carcinoma. In addition to its small molecule platform, the company is also developing dual-chimeric antigen receptor (CAR) T-cell programs.

Recent filings

Filing Released Lang Actions
424B3
Board/Management Information Classification · 95% confidence The document is a Form 8-K current report filed pursuant to the Securities Exchange Act of 1934. It details the election of a new director, Thomas Malley, to the Board of Directors, including his background, stock option grants, and fees related to his board service. The content focuses on changes in the company's board composition and related compensatory arrangements. There are no financial statements or comprehensive financial data presented, nor is this a report publication announcement or a certification. The primary subject is the appointment of a director and related board information, which fits the category of Board/Management Information (MANG). The document length (8292 characters) supports it being a substantive filing rather than a brief announcement. Therefore, the appropriate classification is MANG with high confidence.
2012-10-30 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is used for current reports on significant events. The content specifically details the election of a new director to the Board of Directors, including information about the director's background, stock option grants, fees, and indemnification agreements. This matches the description of announcements related to changes in the company's board or senior management. There is no financial data or report attached, nor is this an announcement of a report publication. Therefore, the document fits the category of Board/Management Information (MANG). The document length is sufficient and the content is focused on management changes, confirming the classification with high confidence.
2012-10-30 English
FORM 4 -
Director's Dealing
2012-10-26 English
FORM 3 -
Director's Dealing
2012-10-26 English
Regulatory Filings 2012
Regulatory Filings
2012-09-14 English
S-1
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used for registering securities for public offering. It includes a prospectus with detailed information about the company, the offering, risk factors, management discussion, financial statements, and other disclosures. This type of filing is related to capital raising and financing activities. It is not an annual report, earnings release, or any other type of report but specifically a registration statement for securities offering under the Securities Act of 1933. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed offering information, confirming it is not merely an announcement but the actual registration statement/prospectus.
2012-08-29 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.